Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Erythromycin D3

Erythromycin D3

NA

DISCOVER
17beta-Estradiol-2,4,16,16 D4

17beta-Estradiol-2,4,16,16 D4

66789-03-5

DISCOVER
Epiandrosterone

Epiandrosterone

481-29-8

DISCOVER
Etaconazole

Etaconazole

60207-93-4

DISCOVER
(S)-Citalopram Oxalate - Escitalopram

(S)-Citalopram Oxalate - Escitalopram

219861-08-2

DISCOVER
Eslicarbazepine

Eslicarbazepine

104746-04-5

DISCOVER
Eperisone HCl

Eperisone HCl

56839-43-1

DISCOVER
Etiocholanolone

Etiocholanolone

53-42-9

DISCOVER
Eletriptan hydrobromide

Eletriptan hydrobromide

177834-92-3

DISCOVER
Enzalutamide

Enzalutamide

915087-33-1

DISCOVER
Emtricitabine

Emtricitabine

143491-57-0

DISCOVER
16alpha-hydroxy Estrone

16alpha-hydroxy Estrone

566-76-7

DISCOVER